Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis

Pancreas

Volumn 18, Issue 4, 1999, Pages 371-377

  Berney, Thierry ^a   Gasche, Yvan ^a   Robert, John ^a   Jenny, Alexandra ^a   Mensi, Noury ^a   Grau, Georges ^a   Vermeulen, Bernard ^a   Morel, Philippe ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Acute pancreatitis; Interleukin 10; Interleukin 6; Interleukin 8; Severity

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0032960716     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199905000-00007     Document Type: Article

References (33)

1. Bradley EL III. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg 1993;128:586-90.
2. Bradley EL III. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg 1993;128:586-90.
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1993;20:864-74.
4. Kusske AM, Rongione AJ, Reber HA. Cytokines and acute pancreatitis. Gastroenterology 1996;110:639-42.
5. Beger HG, Bittner R, Block S, Buchler M. Bacterial contamination of pancreatic necrosis: a prospective clinical study. Gastroenterology 1986;91:433-8.
6. Rinderknecht H. Fatal pancreatitis: a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988;3:105-12.
7. Dominguez-Munoz JE, Carballo F, Garcia MJ et al. Monitoring of serum proteinase-antiproteinase balance and systemic inflammatory response in prognostic evaluation of acute pancreatitis: results of a prospective multicenter study. Dig Dis Sci 1993;38:507-13.
8. Formela LJ, Galloway SW, Kingsnorth AN. Inflammatory mediators in acute pancreatitis. Br J Surg 1995;82:6-13.
9. Schölmerich J. Interleukins in acute pancreatitis. Scand J Gastroenterol Suppl 1996;219:37-42.
10. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 1985;229:869-71.
11. Tracey KJ, Fong Y, Hesse DG, et al. Anti cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987;330:662-4.
12. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock: association between interleukin-6, interleukin-1, and fatal outcome. J Exp Med 1989;169:333-8.
13. Hack CE, Hart M, van Schijndel RJ, et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992; 60:2835-42.
14. Noman JG, Fink GW, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995;130:966-70.
15. Paajanen H, Laato M, Jaakkola M, Pulkki K, Niinikoski J, Nordback I. Serum tumor necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis. Br J Surg 1995;82:271-3.
16. McKay CJ, Gallagher G, Brooks B, Imrie CW, Baxter JN. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996;83:919-23.
17. Inagaki T, Hoshino M, Hayakawa T, et al. Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas 1997;14:1-8.
18. Leser HG, Gross V, Rückauer K, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-5.
19. Viedma JA, Mateo MP, Dominguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis: comparison with C-reactive protein and phospholipase A. Gut 1992;33:1264-7.
20. 2-microglobulin in early assessment of severity of acute pancreatitis: comparison with serum C-reactive protein. Dig Dis Sci 1995;40:2341-8.
21. De Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KCH. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83.349-53.
22. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
23. Van Laethem JL, Marchant A, Delvaux A, et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995;108:1917-22.
24. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, McFadden DW. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997;112:960-7
25. Pezzilli R, Billi P, Miniero R, Barakat B. Serum interleukin-10 in human acute pancreatitis. Dig Dis Sci 1997;42:1469-72.
26. De Beaux AC, Ross JA, Maingay JP, Fearon KCH, Carter DC. Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg 1996; 83:1071-5.
27. Castell JV, Gomez-Lechon MJ, David M, et al. Interleukin-6 is the major regulator of acute-phase protein synthesis in adult human hepatocytes. FEBS Lett 1989;242:237-9.
28. - generation and neutrophil accumulation in rat lungs after acute necrotizing pancreatitis. Surgery 1995;118:547-54.
29. Uhl W, Buchler M, Malfertheiner P, Martini M, Beger HG. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators in human acute pancreatitis. Pancreas 1991;6:253-9.
30. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
31. Grewal HP, Mohey el Din A, Gaber L, Kotb M, Gaber AO. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-α polyclonal antibody. Am J Surg 1994;167:214-9.
32. Norman J, Franz M, Messina J, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995;117:648-55.
33. Kingsnorth AN, Galloway SW, Formela LJ. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg 1995,82:1414-20.